Cliff Asness’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.5M | Buy |
902,650
+790,593
| +706% | +$7.08M | ﹤0.01% | 1672 |
|
|
2026
Q1 | $912K | Sell |
112,057
-34,676
| -24% | -$314K | ﹤0.01% | 2822 |
|
|
2025
Q4 | $986K | Sell |
146,733
-32,977
| -18% | -$249K | ﹤0.01% | 2564 |
|
|
2025
Q3 | $1.56M | Buy |
179,710
+162,111
| +921% | +$1.26M | ﹤0.01% | 2147 |
|
|
2025
Q2 | $111K | Sell |
17,599
-26,828
| -60% | -$178K | ﹤0.01% | 3158 |
|
|
2025
Q1 | $285K | Buy |
44,427
+21,663
| +95% | +$179K | ﹤0.01% | 2713 |
|
|
2024
Q4 | $183K | Buy |
22,764
+4,007
| +21% | +$38.6K | ﹤0.01% | 2689 |
|
|
2024
Q3 | $237K | Buy |
+18,757
| New | +$242K | ﹤0.01% | 2496 |
|
|
2022
Q1 | – | Sell |
-1,573
| Closed | -$225K | – | 2266 |
|
|
2021
Q4 | $225K | Buy |
+1,573
| New | +$270K | ﹤0.01% | 2056 |
|
|
2021
Q3 | – | Sell |
-28,679
| Closed | -$6.09M | – | 2298 |
|
|
2021
Q2 | $6.09M | Sell |
28,679
-13,101
| -31% | -$2.4M | 0.01% | 794 |
|
|
2021
Q1 | $7.58M | Buy |
41,780
+854
| +2% | +$170K | 0.01% | 734 |
|
|
2020
Q4 | $4.56M | Sell |
40,926
-6,598
| -14% | -$701K | 0.01% | 810 |
|
|
2020
Q3 | $5.15M | Buy |
47,524
+25,039
| +111% | +$3.05M | 0.01% | 765 |
|
|
2020
Q2 | $1.87M | Buy |
+22,485
| New | +$860K | ﹤0.01% | 1181 |
|
|
2019
Q2 | – | Sell |
-586
| Closed | -$6K | – | 2145 |
|
|
2019
Q1 | $6K | Sell |
586
-6,571
| -92% | -$207K | ﹤0.01% | 2159 |
|
|
2018
Q4 | $263K | Buy |
7,157
+1,969
| +38% | +$76.3K | ﹤0.01% | 2002 |
|
|
2018
Q3 | $195K | Sell |
5,188
-2,857
| -36% | -$80.4K | ﹤0.01% | 2197 |
|
|
2018
Q2 | $216K | Buy |
+8,045
| New | +$272K | ﹤0.01% | 2204 |
|
|
2016
Q4 | – | Sell |
-12,842
| Closed | -$534K | – | 2272 |
|
|
2016
Q3 | $534K | Buy |
12,842
+5,411
| +73% | +$699K | ﹤0.01% | 1920 |
|
|
2016
Q2 | $1.08M | Buy |
7,431
+3,789
| +104% | +$434K | ﹤0.01% | 1590 |
|
|
2016
Q1 | $376K | Sell |
3,642
-6,353
| -64% | -$682K | ﹤0.01% | 1930 |
|
|
2015
Q4 | $1.68M | Sell |
9,995
-1,442
| -13% | -$222K | ﹤0.01% | 1327 |
|
|
2015
Q3 | $1.62M | Buy |
11,437
+733
| +7% | +$164K | ﹤0.01% | 1227 |
|
|
2015
Q2 | $2.38M | Buy |
10,704
+6,079
| +131% | +$1.07M | ﹤0.01% | 1108 |
|
|
2015
Q1 | $765K | Sell |
4,625
-3,585
| -44% | -$582K | ﹤0.01% | 1533 |
|
|
2014
Q4 | $974K | Sell |
8,210
-2,650
| -24% | -$277K | ﹤0.01% | 1658 |
|
|
2014
Q3 | $906K | Hold |
10,860
| – | – | ﹤0.01% | 1663 |
|
|
2014
Q2 | $1M | Hold |
10,860
| – | – | ﹤0.01% | 1648 |
|
|
2014
Q1 | $984K | Buy |
10,860
+4,200
| +63% | +$469K | ﹤0.01% | 1713 |
|
|
2013
Q4 | $682K | Buy |
6,660
+1,530
| +30% | +$108K | ﹤0.01% | 1912 |
|
|
2013
Q3 | $324K | Hold |
5,130
| – | – | ﹤0.01% | 2175 |
|
|
2013
Q2 | $210K | Buy |
+5,130
| New | +$222K | ﹤0.01% | 2205 |
|
Other funds holding NVAX
SCM
S
Cliff Asness's NVAX Position: Q2 2026 in Review
Cliff Asness increased its Novavax (NVAX) stake by 706% in Q2 2026, buying an estimated $7.08M and bringing the position to 902,650 shares worth $8.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1672.
Cliff Asness first reported a position in NVAX in Q2 2013 and has held it in 32 quarters since. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Cliff Asness held 902,650 shares of Novavax worth $8.5M as of Q2 2026.
- Cliff Asness bought 790,593 Novavax shares in Q2 2026, an estimated $7.08M.
- Novavax made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1672 holding.
- Cliff Asness first reported a position in Novavax in Q2 2013 and has held it in 32 quarters since.
- 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.